Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation
X Yao, NS Abraham, GC Alexander… - Journal of the …, 2016 - Am Heart Assoc
Background In comparison to warfarin, non–vitamin K antagonist oral anticoagulants (NOAC
s) have the advantages of ease of dosing, fewer drug interactions, and lack of need for …
s) have the advantages of ease of dosing, fewer drug interactions, and lack of need for …
[HTML][HTML] Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration
RT Borne, C O'Donnell, MP Turakhia… - BMC cardiovascular …, 2017 - Springer
Background The direct oral anticoagulants (DOACs) reduce the risk of stroke in moderate to
high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its …
high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its …
Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies
Introduction Medications cannot exert their effect if not taken as prescribed by patients. Our
objective was to summarise the observational evidence on adherence to oral anticoagulants …
objective was to summarise the observational evidence on adherence to oral anticoagulants …
Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
A Banerjee, V Benedetto, P Gichuru, J Burnell… - Heart, 2020 - heart.bmj.com
Background Despite simpler regimens than vitamin K antagonists (VKAs) for stroke
prevention in atrial fibrillation (AF), adherence (taking drugs as prescribed) and persistence …
prevention in atrial fibrillation (AF), adherence (taking drugs as prescribed) and persistence …
Oral anticoagulant prescription trends, profile use, and determinants of adherence in patients with atrial fibrillation
S Perreault, S de Denus, B White‐Guay… - … : The Journal of …, 2020 - Wiley Online Library
Background and Purpose Data on oral anticoagulant (OAC) uptake and pattern of use are
limited. Real‐life data in patients with atrial fibrillation (AF) are important for understanding …
limited. Real‐life data in patients with atrial fibrillation (AF) are important for understanding …
Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-naive nonvalvular atrial fibrillation
BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used for
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
prevention of stroke secondary to nonvalvular atrial fibrillation (NVAF). Increased use of …
Adherence to oral anticoagulant therapy in patients with atrial fibrillation
Oral anticoagulation is pivotal in the management of thromboembolic risk in non-valvular
atrial fibrillation (NVAF) patients. Effective anticoagulation is important to avoid major …
atrial fibrillation (NVAF) patients. Effective anticoagulation is important to avoid major …
Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
AF Ozaki, AS Choi, QT Le, DT Ko, JK Han… - … Quality and Outcomes, 2020 - Am Heart Assoc
Background: Stroke reduction with direct oral anticoagulants (DOACs) in atrial fibrillation
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …
Changes in oral anticoagulation therapy over one year in 51,000 atrial fibrillation patients at risk for stroke: a practice-derived study
SH Hohnloser, E Basic… - Thrombosis and …, 2019 - thieme-connect.com
Background This study assessed changes in anticoagulation therapy over time in patients
with atrial fibrillation (AF). Methods Analyses were performed on a claims-based dataset of 4 …
with atrial fibrillation (AF). Methods Analyses were performed on a claims-based dataset of 4 …
The optimal drug adherence to maximize the efficacy and safety of non-vitamin K antagonist oral anticoagulant in real-world atrial fibrillation patients
Aims To investigate the association between adherence to non-vitamin K antagonist oral
anticoagulant (NOAC) and clinical outcomes and to determine the optimal cut-off level of …
anticoagulant (NOAC) and clinical outcomes and to determine the optimal cut-off level of …